Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34012442/
Adoptive immunotherapy using chimeric antigen receptor (CAR)-T cells has achieved successful remissions in refractory B-cell leukemia and B-cell lymphomas. In order to estimate both success and severe side effects of CAR-T cell therapies, longitudinal monitoring of the patient's immune system includ ...
-
Mark FeslerMay 31, 2021This is very important work that will not only lead to better prognostication and prediction with car T therapy but also lead to commercially available assays for current constructs